Home LiteratureArticle Details
PMID: 29948806 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD.

Journal of general internal medicine ·Vol. 33 ·No. 9 ·2018-00-00 ·Pages 1461-1468

Goto T, Shimada YJ, Faridi MK, Camargo CA, Hasegawa K

Abstract

There is a lack of comprehensive view of the association between acute exacerbation of COPD (AECOPD) and the risk of acute cardiovascular events. To determine the association of AECOPD with 30-day and 1-year incidences of acute cardiovascular event. Self-controlled case series analysis using population-based datasets from three US states from 2005 through 2011. Patients aged ≥ 40 years with AECOPD. The primary outcome was a composite of an ED visit or hospitalization for acute cardiovascular events, including acute myocardial infarction, heart failure, atrial fibrillation, pulmonary embolism, and stroke. We compared the incidence of each patient's acute cardiovascular event during the first 30-day period before the index AECOPD (30-day reference period) in comparison with that during the 30-day period after the index AECOPD. Likewise, with the 1-year period before the index AECOPD as reference, we also estimated incidence rate ratios (IRRs) for each patient's outcomes during 1-year period after the index AECOPD. Overall, there were 362,867 patients with an ED visit or hospitalization for AECOPD. Compared with the 30-day reference period, the incidence of acute cardiovascular event in the 30-day period after the AECOPD was significantly higher (IRR, 1.34; 95%CI, 1.30-1.39; P < 0.001). Likewise, compared with the 1-year reference period, the incidence during the 1-year period after the AECOPD was also higher (IRR, 1.20; 95%CI, 1.18-1.22; P < 0.001). For each of acute cardiovascular conditions, the associations remained significant (all P < 0.05). AECOPD was associated with increased 30-day and 1-year incidences of acute cardiovascular event.

Keywords
COPD acute exacerbation of COPD cardiovascular diseases
MeSH Terms
Acute Disease Aged Cardiovascular Diseases/classification,epidemiology,etiology,therapy Correlation of Data Female Hospitalization/statistics & numerical data Humans Incidence Male Middle Aged Outcome Assessment, Health Care Pulmonary Disease, Chronic Obstructive/complications,diagnosis,epidemiology Risk Assessment/methods,statistics & numerical data Risk Factors Symptom Flare Up United States/epidemiology
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Goto Tadahiro
Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA. [email protected].
Shimada Yuichi J
Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Faridi Mohammad Kamal
Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
Camargo Carlos A
Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
Hasegawa Kohei
Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA.
References (41)
41 references, click to expand
  1. Venous thromboemboli and exacerbations of COPD.
    Eur Respir J. 2010 Jun;35(6):1243-8 PMID: 19926740
  2. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Lancet Respir Med. 2015 Aug;3(8):631-9 PMID: 26208998
  3. Mortality in COPD: Role of comorbidities.
    Eur Respir J. 2006 Dec;28(6):1245-57 PMID: 17138679
  4. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.
    Thorax. 2007 May;62(5):411-5 PMID: 17311843
  5. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2013 Nov 1;188(9):1091-9 PMID: 24033321
  6. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.
    JAMA. 2011 Oct 19;306(15):1669-78 PMID: 22009099
  7. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.
    Circulation. 2013 Dec 17;128(24):2577-84 PMID: 24190958
  8. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
    Thorax. 2005 Nov;60(11):925-31 PMID: 16055622
  9. Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.
    JAMA Intern Med. 2015 Jun;175(6):1060-2 PMID: 25894761
  10. Positive predictive values of ICD-9 codes to identify patients with stroke or TIA.
    Am J Manag Care. 2014 Feb 01;20(2):e27-34 PMID: 24738552
  11. Cardiac disease in chronic obstructive pulmonary disease.
    Proc Am Thorac Soc. 2008 May 1;5(4):543-8 PMID: 18453369
  12. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD.
    Respirology. 2016 May;21(4):761-4 PMID: 26699685
  13. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.
    Ann Am Thorac Soc. 2014 Jun;11(5):685-94 PMID: 24784958
  14. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.
    Chest. 2004 Jun;125(6):2309-21 PMID: 15189956
  15. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011.
    Chest. 2015 Apr;147(4):989-998 PMID: 25375955
  16. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.
    J Glob Health. 2015 Dec;5(2):020415 PMID: 26755942
  17. The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations.
    Chest. 2012 Jan;141(1):87-93 PMID: 21757568
  18. Risk of myocardial infarction and stroke after acute infection or vaccination.
    N Engl J Med. 2004 Dec 16;351(25):2611-8 PMID: 15602021
  19. Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2013 Apr 1;187(7):715-20 PMID: 23328521
  20. Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department.
    Jt Comm J Qual Patient Saf. 2008 Nov;34(11):678-80 PMID: 19025089
  21. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Arch Intern Med. 2010 May 24;170(10):880-7 PMID: 20498416
  22. COPD disease severity and the risk of venous thromboembolic events: a matched case-control study.
    Int J Chron Obstruct Pulmon Dis. 2016 Apr 28;11:899-908 PMID: 27175072
  23. Validating administrative data in stroke research.
    Stroke. 2002 Oct;33(10):2465-70 PMID: 12364739
  24. An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27 PMID: 25830527
  25. Tutorial in biostatistics: the self-controlled case series method.
    Stat Med. 2006 May 30;25(10):1768-97 PMID: 16220518
  26. Increased risk of myocardial infarction and stroke following exacerbation of COPD.
    Chest. 2010 May;137(5):1091-7 PMID: 20022970
  27. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning.
    Circulation. 2014 Jun 10;129(23):2371-9 PMID: 24842943
  28. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence.
    Thorax. 2010 Oct;65(10):930-6 PMID: 20627907
  29. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23 PMID: 11719299
  30. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.
    Med Care. 2005 May;43(5):480-5 PMID: 15838413
  31. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study.
    Am J Respir Crit Care Med. 2016 Feb 1;193(3):251-8 PMID: 26414484
  32. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.
    Am Heart J. 2004 Jul;148(1):99-104 PMID: 15215798
  33. Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease.
    Respir Res. 2014 Apr 10;15:40 PMID: 24717062
  34. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis.
    Chest. 2017 Mar;151(3):544-554 PMID: 27522956
  35. A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study.
    Chest. 2018 Jul;154(1):41-50 PMID: 29246770
  36. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    N Engl J Med. 2007 Feb 22;356(8):775-89 PMID: 17314337
  37. Risk of an asthma exacerbation after bariatric surgery in adults.
    J Allergy Clin Immunol. 2015 Aug;136(2):288-94.e8 PMID: 25670012
  38. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis.
    Chest. 2009 Mar;135(3):786-793 PMID: 18812453
  39. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD.
    Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2908-17 PMID: 25339486
  40. The association of aspirin use with severity of acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study.
    NPJ Prim Care Respir Med. 2018 Feb 21;28(1):7 PMID: 29467461
  41. Determinants of endothelial function in patients with COPD.
    Eur Respir J. 2013 Nov;42(5):1194-204 PMID: 23429917
Article Info
Journal
Journal of general internal medicine
Abbr.
J Gen Intern Med
ISSN
1525-1497
Published
2018-00-00
Epub
2018-00-08
Pages
1461-1468
Language
English
Region
United States
NLM ID
8605834
PMCID
PMC6108996
Subset
IM
Grants
AHRQ HHS · R01 HS023305 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]